Effects of teprotumumab on patients with long-standing, active thyroid eye disease

PURPOSE: Describe five cases of long-standing, active thyroid eye disease that responded to treatment with teprotumumab. OBSERVATIONS: Five patients with a greater than 9-month-history of thyroid eye disease, including two patients who had previously failed orbital radiotherapy, received eight doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinson, Kyle B., Kirzhner, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987648/
https://www.ncbi.nlm.nih.gov/pubmed/35402750
http://dx.doi.org/10.1016/j.ajoc.2022.101348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987648/
https://www.ncbi.nlm.nih.gov/pubmed/35402750
http://dx.doi.org/10.1016/j.ajoc.2022.101348

Ejemplares similares